top of page


Using its library of patented polymers, ANP has successfully nanoencapsulated poorly soluble drugs to improve their pharmacokinetics, reduce toxicity, and enhance their therapeutic efficacy. This technology has allowed our drugs to show great promise under clinical trials. Because of this success, we have developed an even wider variety of drugs in our pipeline, including various antibodies, small molecules, peptides, and vaccines for diseases such as cancers and ebola. In addition, ANP has collaborated with drug companies to nanoencapsulate their poorly soluble drugs for IV and IM injections. Our innovative technology in therapeutics is resulting in a transformation in health care.

ANP Drug Pipeline

bottom of page